Tanya Cranfield Selected Research

Hemorrhage

1/2021

Real-world experience with caplacizumab in the management of acute TTP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tanya Cranfield Research Topics

Disease

4	Thrombotic Thrombocytopenic Purpura 01/2021 - 06/2016
2	acquired Thrombotic thrombocytopenic purpura 01/2022 - 06/2016
1	Rare Diseases (Rare Disease) 01/2022
1	Hemorrhage 01/2021
1	Lethargy 11/2019
1	Headache (Headaches) 11/2019
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Stroke (Strokes) 11/2019
1	Heart Arrest (Cardiac Arrest) 06/2016
1	Nocardia Infections 11/2008
1	Lymphoma (Lymphomas) 11/2008
1	Multiple Myeloma 01/2003

Drug/Important Bio-Agent (IBA)

3	thiamine triphosphorate (TTP)IBA 01/2021 - 06/2016
2	Metalloproteases (Metalloproteinases)IBA 11/2019 - 06/2016
2	ThrombospondinsIBA 11/2019 - 06/2016
2	DisintegrinsIBA 11/2019 - 06/2016
1	VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	caplacizumabIBA 01/2021
1	AntigensIBA 01/2017
1	AntibodiesIBA 01/2017
1	Bortezomib (Velcade)FDA Link 06/2016
1	AutoantibodiesIBA 06/2016
1	fludarabineIBA 11/2008
1	ParaproteinsIBA 01/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 11/2019
1	Plasma Exchange 01/2021